Procter & Gamble Cash & Equivalents increased by 13.7% to $12.31B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 35.0%, from $9.12B to $12.31B. Over 4 years (FY 2021 to FY 2025), Cash & Equivalents shows relatively stable performance with a -1.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.29B | $10.37B | $11.54B | $8.53B | $7.21B | $6.71B | $6.85B | $7.60B | $8.25B | $9.73B | $7.89B | $6.83B | $9.48B | $12.16B | $10.23B | $9.12B | $9.56B | $11.17B | $10.83B | $12.31B |
| QoQ Change | — | +0.8% | +11.3% | -26.1% | -15.4% | -7.0% | +2.1% | +10.8% | +8.6% | +18.0% | -18.9% | -13.5% | +38.9% | +28.2% | -15.8% | -10.9% | +4.8% | +16.9% | -3.1% | +13.7% |
| YoY Change | — | — | — | — | -29.9% | -35.3% | -40.6% | -10.9% | +14.3% | +45.1% | +15.1% | -10.1% | +15.0% | +24.9% | +29.7% | +33.5% | +0.8% | -8.1% | +5.8% | +35.0% |